Covidien PLC (COV)

106.71
1.36 1.26
Prev Close 108.07
Open 107.97
Day Low/High 106.71 / 108.16
52 Wk Low/High 65.97 / 108.57
Volume 24.76M
Avg Volume 3.84M
Exchange
Shares Outstanding 454.51M
Market Cap 48.50B
EPS 3.68
Div & Yield 1.44 (1.30%)

Latest News

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named...

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

Today Covidien (COV) Hits New Lifetime High

Today Covidien (COV) Hits New Lifetime High

Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien Supports Retreat & Refresh Stroke Camp For Stroke Survivors And Caregivers

Covidien is sponsoring the Retreat & Refresh Stroke Camp (Stroke Camp), a three-day retreat for stroke survivors, caregivers and family members dedicated to helping these often forgotten victims of stroke relax...

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) Stock Rises Today on Earnings Beat

Covidien (COV) shares are climbing after the company reported its first quarter earnings results.

Covidien Reports First-Quarter 2015 Results

Covidien Reports First-Quarter 2015 Results

Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2015.

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

What to Expect When Covidien (COV) Reports First-Quarter Earnings Tomorrow

Shares of Covidien (COV) closed higher Wednesday ahead of the healthcare company's first-quarter earnings report before the market open Thursday.